Preliminary experiments indicate conolidine could inhibit particular ion channels, cutting down neuronal excitability and restricting soreness signals. This mechanism is particularly pertinent in neuropathic pain, the place abnormal signaling will cause persistent irritation. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR)